CN103966315A - Fluorescence quantitative PCR (polymerase chain reaction) detection method for 14 serotypes of Uu (ureaplasma urealyticum) - Google Patents
Fluorescence quantitative PCR (polymerase chain reaction) detection method for 14 serotypes of Uu (ureaplasma urealyticum) Download PDFInfo
- Publication number
- CN103966315A CN103966315A CN201410113941.6A CN201410113941A CN103966315A CN 103966315 A CN103966315 A CN 103966315A CN 201410113941 A CN201410113941 A CN 201410113941A CN 103966315 A CN103966315 A CN 103966315A
- Authority
- CN
- China
- Prior art keywords
- serotypes
- quantitative pcr
- dna
- ureaplasma urealyticum
- artificial sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000003753 real-time PCR Methods 0.000 title claims abstract description 24
- 241000202921 Ureaplasma urealyticum Species 0.000 title claims abstract description 20
- 238000001514 detection method Methods 0.000 title claims abstract description 11
- 238000003752 polymerase chain reaction Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract description 42
- 239000000523 sample Substances 0.000 claims abstract description 26
- 238000011529 RT qPCR Methods 0.000 claims abstract description 5
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229910001425 magnesium ion Inorganic materials 0.000 claims abstract description 4
- 230000003321 amplification Effects 0.000 claims description 8
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 8
- 210000002966 serum Anatomy 0.000 claims 1
- 230000007918 pathogenicity Effects 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 238000010170 biological method Methods 0.000 abstract 1
- 241000935255 Ureaplasma parvum Species 0.000 description 9
- 239000006166 lysate Substances 0.000 description 9
- 108010067770 Endopeptidase K Proteins 0.000 description 8
- 239000000203 mixture Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 4
- 238000012802 pre-warming Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000013641 positive control Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 206010060937 Amniotic cavity infection Diseases 0.000 description 1
- 208000008158 Chorioamnionitis Diseases 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 208000004145 Endometritis Diseases 0.000 description 1
- 206010058780 Meningitis neonatal Diseases 0.000 description 1
- 241000204003 Mycoplasmatales Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 101100180314 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) IST2 gene Proteins 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 210000003679 cervix uteri Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000006853 reporter group Chemical group 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 238000007862 touchdown PCR Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 238000012070 whole genome sequencing analysis Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种解脲脲原体14种血清型荧光定量PCR检测方法,该方法14种血清型均采用20微升反应体系,其中引物和探针的终浓度均为0.2微摩尔每升(uM),镁离子终浓度染料法为2毫摩尔每升(mM),探针法为3mM,染料法加10微升qPCRMasterMix,探针法加10微升定量PCRSuperMix-UDG。本发明首次实现了用分子生物学方法对解脲脲原体的14种血清型进行分型,解决了传统分型方法灵敏度低、重复性差的缺点,为今后在血清型水平进一步研究解脲脲原体的致病性打下了方法学基础,可广泛应用于临床。The invention discloses a fluorescent quantitative PCR detection method for 14 serotypes of Ureaplasma urealyticum. The method uses a 20 microliter reaction system for all 14 serotypes, and the final concentrations of primers and probes are both 0.2 micromole per liter. (uM), the final concentration of magnesium ions is 2 millimoles per liter (mM) for the dye method, and 3 mM for the probe method. Add 10 microliters of qPCR MasterMix for the dye method, and 10 microliters of quantitative PCRSuperMix-UDG for the probe method. The present invention realizes the typing of 14 serotypes of Ureaplasma urealyticum by molecular biological method for the first time, solves the shortcomings of low sensitivity and poor repeatability of traditional typing methods, and provides a basis for further research on urealyticum urealyticum at the level of serotypes in the future The pathogenicity of the protozoa has laid a methodological foundation and can be widely used in clinical practice.
Description
技术领域 technical field
本发明涉及基因领域,尤其涉及一种解脲脲原体14种血清型荧光定量PCR检测方法。 The invention relates to the field of genes, in particular to a fluorescent quantitative PCR detection method for 14 serotypes of Ureaplasma urealyticum.
背景技术 Background technique
解脲脲原体(Ureaplasma urealyticum,Uu)是人类泌尿生殖道中一种常见的共生型微生物,但同时也和各种疾病有关,如非淋球菌性尿道炎(宫颈炎)、子宫内膜炎、绒毛膜羊膜炎、新生儿脑膜炎、肺炎等。 Ureaplasma urealyticum (Uu) is a common symbiotic microorganism in the human genitourinary tract, but it is also associated with various diseases, such as non-gonococcal urethritis (cervicitis), endometritis, Chorioamnionitis, neonatal meningitis, pneumonia, etc.
Uu目前已知的有14种血清型,最近14种血清型又根据各种标准被划分为两个生物群,即微小脲原体(Ureaplasma parvum,UPA)包括血清型1,3,6,14和解脲脲原体(Ureaplasma urealyticum,UUR)包括其余10种血清型。 There are currently 14 known serotypes of Uu, and the 14 serotypes have recently been divided into two biological groups according to various criteria, namely Ureaplasma parvum (UPA), including serotypes 1, 3, 6, and 14 Ureaplasma urealyticum (UUR) includes the remaining 10 serotypes.
多年来人们一直在猜测Uu的致病性是否和某一特定的生物群或血清型有关,尽管很多研究报道UUR比UPA更具有致病性,但也有学者并不同意此观点。所以Uu不同的致病性很可能和不同血清型有关而不是生物群,推测某一类疾病和特定血清型之间的相关性就需要一种准确、可行的分型方法。 For many years, people have been speculating whether the pathogenicity of Uu is related to a specific biological group or serotype. Although many studies have reported that UUR is more pathogenic than UPA, some scholars do not agree with this view. Therefore, the different pathogenicity of Uu is likely to be related to different serotypes rather than biological groups. An accurate and feasible typing method is required to speculate on the correlation between a certain type of disease and a specific serotype.
传统的基于抗体为基础的分型方法包括生长/代谢抑制试验、酶联免疫吸附试验、免疫印迹法等,抗血清不仅制备繁琐、难以商品化,并且敏感性和稳定性不够,特别是当同一标本中含有两种或以上血清型的时候,分辨能力和重复性都较差。 Traditional antibody-based typing methods include growth/metabolism inhibition test, enzyme-linked immunosorbent assay, western blotting, etc. Antisera are not only cumbersome to prepare, difficult to commercialize, but also have insufficient sensitivity and stability, especially when the same When the specimen contains two or more serotypes, the resolution and repeatability are poor.
近年来以基因为基础的Uu分型方法中,引物和探针的设计大多是针对多条带抗原(multiple-band antigen MBA)基因5’末端序列的差异来来设计的,结合直接测序或限制性内切酶分析,这些试验能把UPA的4个血清型型分开,但只能把UUR的10个血清型分成若干个组。最近Xiao等(Xiao L,Glass J I,Paralanov V,et al.Detection and characterization of human Ureaplasma species and serovars by real-time PCR[J].J Clin Microbiol,2010,48(8):2715-2723.)用荧光定量PCR(Fluorescence Quantitative PCR,FQ-PCR)建立了一套Uu分群和分型的方法,成功把14种血清型分开且没有交叉反应。与传统PCR相比荧光定量PCR法具有能定量、更灵敏、快速并不容易被污染的特点,在基因表达水平分析、病原体的定性、定量检测等方面得到了广泛的应用。但由于Xiao等建立的方法检测14种血清型的PCR扩增条件各不相同,使得在实际操作中非常耗时与繁琐,因此很难在临床中广泛开展。 In the gene-based Uu typing methods in recent years, most of the primers and probes are designed for the difference in the 5' end sequence of the multiple-band antigen (MBA) gene, combined with direct sequencing or restriction Endonuclease analysis, these tests can separate the 4 serotypes of UPA, but can only divide the 10 serotypes of UUR into several groups. Recently Xiao et al. (Xiao L, Glass J I, Paralanov V, et al. Detection and characterization of human Ureaplasma species and serovars by real-time PCR[J].J Clin Microbiol,2010,48(8):2715-2723.) Fluorescence Quantitative PCR (FQ-PCR) was used to establish a method for Uu grouping and typing, which successfully separated 14 serotypes without cross-reaction. Compared with traditional PCR, fluorescent quantitative PCR method has the characteristics of quantitative, more sensitive, fast and not easy to be contaminated, and has been widely used in the analysis of gene expression level, qualitative and quantitative detection of pathogens, etc. However, because the method established by Xiao et al. has different PCR amplification conditions for detecting 14 serotypes, it is very time-consuming and cumbersome in actual operation, so it is difficult to be widely used in clinical practice.
发明内容 Contents of the invention
本发明的目的在于针对现有技术的不足,提供了一种解脲脲原体14种血清型荧光定量PCR检测方法,本发明在结合文献的基础上通过对Uu14种血清型基因组进行分析,重新设计部分引物和探针并优化实验条件,建立一套准确而又切实可行的Uu14种血清型荧光定量PCR检测方法,对Uu致病性的研究和临床应用都具有非常重要的意义。 The object of the present invention is to aim at the deficiencies in the prior art, provide a kind of fluorescent quantitative PCR detection method of 14 kinds of serotypes of U. Designing some primers and probes, optimizing experimental conditions, and establishing an accurate and feasible fluorescent quantitative PCR detection method for Uu14 serotypes are of great significance to the research and clinical application of Uu pathogenicity.
本发明的目的是通过以下技术方案来实现的: The purpose of the present invention is achieved through the following technical solutions:
蛋白酶K裂解液:取5.0ml KCl(1mol/L)、0.25ml MgCl2(1mol/L)、1.5ml Tris-HCl(1mol/L,PH8.0)、Tween-20(20%)混合即为裂解液,裂解液和蛋白酶K(200μg/ml)以50:2的体积混合后,即为DNA模板提取所用的蛋白酶K裂解液。 Proteinase K lysate: Mix 5.0ml KCl (1mol/L), 0.25ml MgCl 2 (1mol/L), 1.5ml Tris-HCl (1mol/L, pH8.0), Tween-20 (20%) The lysate, lysate and proteinase K (200μg/ml) are mixed at a volume of 50:2, which is the proteinase K lysate used for DNA template extraction.
荧光定量PCR在罗氏Light Cycler480仪器上完成。其中血清型1、3、6、14、2、7、8、9、13共9种用的是SYBR染料法,其余5种用Taqman探针法。 Fluorescent quantitative PCR was completed on Roche Light Cycler480 instrument. Among them, 9 serotypes 1, 3, 6, 14, 2, 7, 8, 9, and 13 were detected by the SYBR dye method, and the remaining 5 were detected by the Taqman probe method.
SYBR染料法和探针法所用的试剂盒分别为Promega GoTaq qPCR Master Mix和Invitrogen定量PCR SuperMix-UDG。 The kits used for SYBR dye method and probe method are Promega GoTaq qPCR Master Mix and Invitrogen quantitative PCR SuperMix-UDG, respectively.
14种血清型均采用20微升反应体系,其中引物和探针的终浓度均为0.2微摩尔每升(uM),镁离子终浓度染料法为2毫摩尔每升(mM),探针法为3mM,染料法加10微升Promega GoTaq qPCR Master Mix,探针法加10微升Invitrogen定量PCR SuperMix-UDG。 All 14 serotypes use a 20 microliter reaction system, in which the final concentration of primers and probes is 0.2 micromoles per liter (uM), the final concentration of magnesium ions is 2 millimoles per liter (mM) for the dye method, and 2 millimoles per liter (mM) for the probe method For the dye method, add 10 microliters of Promega GoTaq qPCR Master Mix, and for the probe method, add 10 microliters of Invitrogen quantitative PCR SuperMix-UDG.
染料法PCR的条件都包括95℃5分钟的预温,接着40个循环扩增,熔解曲线的条件为:95℃5秒(速率为4.4℃/s),65℃1分钟(速率为2.2℃/s),97℃(速率为0.11℃/s)连续采集信号模式。最后仪器冷却程序40℃30秒。探针法的条件包括预温50℃和95℃各2分钟,接着扩增程序。最后仪器冷却程序40℃30秒。其中血清型5、8为了提高特异性用了降落(Touch Down)PCR。详细PCR条件见下表。 The conditions of the dye method PCR include a pre-warming at 95°C for 5 minutes, followed by 40 cycles of amplification. The conditions of the melting curve are: 95°C for 5 seconds (the rate is 4.4°C/s), 65°C for 1 minute (the rate is 2.2°C /s), 97°C (0.11°C/s) continuous acquisition signal mode. The final instrument cooling program was 40°C for 30 seconds. Conditions for the probe method included pre-warming at 50°C and 95°C for 2 minutes each, followed by an amplification procedure. The final instrument cooling program was 40°C for 30 seconds. Among them, serotypes 5 and 8 used Touch Down PCR to improve specificity. See the table below for detailed PCR conditions.
Uu14种血清型标阳性对照采用14种血清型的标准菌株,菌种1-14型对应美国标准菌株保藏中心(ATCC)编号分别为27813、27814、27815、27816、2781727818、27819、21618、33175、33699、33695、33696、33698和33697。阴性对照采用无菌双蒸水。 The standard strains of 14 serotypes are used as positive controls of Uu14 serotypes. The strains 1-14 correspond to the American Standard Strain Collection Center (ATCC) numbers 27813, 27814, 27815, 27816, 2781727818, 27819, 21618, 33175, 33699, 33695, 33696, 33698, and 33697. Sterile double distilled water was used as negative control.
各血清型特异的引物和或Taqman探针见下表 Specific primers and/or Taqman probes for each serotype are listed in the table below
F为上游引物;R为下游引物;P为探针(探针5’端标记报告基团FAM,3’端标记淬灭基团TAMRA) F is the upstream primer; R is the downstream primer; P is the probe (the 5' end of the probe is labeled with the reporter group FAM, and the 3' end is labeled with the quencher group TAMRA)
用解脲脲原体ATCC14种血清型标准菌株来验证其特异性。标准菌株纯化后的DNA浓度(纳克/微升)用分光光度计NanoDrop2000C(购自Thermo Scientific公司)来测定,分子拷贝数(个/微升)=DNA质量浓度/DNA分子量=纳克数×6.02×1014/DNA分子量,DNA分子量=DNA碱基数×649,因为14种血清型只有血清型3和10完成了全基因组测序,所以DNA碱基数UPA按血清型3(0.75-Mb)来计算、UUR按血清型10(0.87-Mb)来计算。成10倍梯度稀释后进行荧光定量PCR,人为设35个循环内有扩增曲线的视为阳性,35循环内能得出阳性结果的最低稀释度的拷贝数即为本试验的敏感度。该试验的检出限范围为22拷贝/微升(血清型1,)到3200拷贝/微升(血清型5)。 Ureaplasma urealyticum ATCC14 serotype standard strains were used to verify its specificity. The DNA concentration (ng/μl) of the purified standard strain was measured with a spectrophotometer NanoDrop2000C (purchased from Thermo Scientific Company), and the molecular copy number (unit/μl)=DNA mass concentration/DNA molecular weight=ng number× 6.02×10 14/ DNA molecular weight, DNA molecular weight=DNA base number×649, because only serotype 3 and 10 of the 14 serotypes have completed the whole genome sequencing, so the DNA base number UPA is based on serotype 3 (0.75-Mb) To calculate, UUR is calculated according to serotype 10 (0.87-Mb). Fluorescent quantitative PCR was performed after 10-fold serial dilution, and the amplification curve within 35 cycles was artificially regarded as positive, and the copy number of the lowest dilution that could yield a positive result within 35 cycles was the sensitivity of the test. The limit of detection of the assay ranged from 22 copies/µl (serotype 1) to 3200 copies/µl (serotype 5).
本发明的有益效果是,本发明通过对引物和探针的设计和反复的试验,首次利用荧光定量PCR法检测解脲脲原体的14种血清型,针对部分血清型PCR条件的优化和统一,特别是对UPA(血清型1、3、6、14)4个血清型的荧光定量PCR反应条件完全进行了统一,极大的方便了实际的操作。 The beneficial effects of the present invention are that, through the design of primers and probes and repeated tests, the present invention detects 14 serotypes of Ureaplasma urealyticum by the fluorescent quantitative PCR method for the first time, and optimizes and unifies PCR conditions for some serotypes , especially the fluorescent quantitative PCR reaction conditions for the four serotypes of UPA (serotypes 1, 3, 6, and 14) are completely unified, which greatly facilitates the actual operation.
附图说明 Description of drawings
图1为血清型1特异的荧光定量PCR标准曲线图; Fig. 1 is the specific fluorescent quantitative PCR standard curve diagram of serotype 1;
图2中,(a)、(b)、(c)、(d)分别为血清型1、3、6、14特异的荧光定量PCR检测14种血清型标准菌株的特异性扩增曲线; In Figure 2, (a), (b), (c), and (d) are the specific amplification curves of 14 serotype standard strains detected by serotype 1, 3, 6, and 14-specific fluorescent quantitative PCR;
图3为女性子宫颈解脲脲原体血清型分布图,其中,(a)为UPA分血清型结果图,(b)为UUR分血清型结果图。 Figure 3 is the serotype distribution diagram of Ureaplasma urealyticum in female cervix, in which (a) is the result diagram of UPA serotype classification, and (b) is the result diagram of UUR serotype classification.
具体实施方式 Detailed ways
下面结合实例对本发明进行详细说明。 The present invention will be described in detail below in conjunction with examples.
标本:体检女性宫颈分泌物标本220例;14种血清型阳性对照:血清型1-14标准菌株,来自东南大学流行病学实验室,菌种1-14型对应美国标准菌株保藏中心(ATCC)编号分别为27813、27814、27815、27816、2781727818、27819、21618、33175、33699、33695、33696、33698和33697。。 Specimens: 220 cases of female cervical secretions for physical examination; 14 serotype positive controls: serotype 1-14 standard strains, from the Epidemiology Laboratory of Southeast University, and strains 1-14 correspond to the American Standard Strain Collection Center (ATCC) The numbers are 27813, 27814, 27815, 27816, 2781727818, 27819, 21618, 33175, 33699, 33695, 33696, 33698 and 33697. .
Uu的分离培养采用Mycoplasma IST2试剂盒(bioMérieus,法国)按说明书进行操作,最终确认为Uu阳性的为106例,阳性液体培养液-80℃冰箱中备用。 Uu was isolated and cultured using the Mycoplasma IST2 kit (bioMérieus, France) according to the instructions, and 106 cases were finally confirmed to be Uu positive, and the positive liquid culture medium was stored in a -80°C refrigerator for later use.
DNA的提取采用蛋白酶K法,简单步骤为:取Uu阳性培养液1毫升,离心(14800转/分钟,离心半径100毫米)10分钟,弃上清液;沉淀中加蛋白酶K裂解液60μL,吹打混匀;55℃消化60分钟,95℃灭活5分钟;离心1分钟,上清液再用QIAamp DNA Mini Kit(购自QIAGEN公司)纯化(按说明书操作)后即为PCR扩增用模板。模板保存在-20℃冰箱中备用。 The proteinase K method is used for DNA extraction. The simple steps are: take 1 ml of Uu-positive culture solution, centrifuge (14800 rpm, centrifugal radius 100 mm) for 10 minutes, discard the supernatant; add 60 μL of proteinase K lysate to the precipitate, pipette Mix well; digest at 55°C for 60 minutes, inactivate at 95°C for 5 minutes; centrifuge for 1 minute, and then purify the supernatant with QIAamp DNA Mini Kit (purchased from QIAGEN) (operate according to the instructions) and then it will be the template for PCR amplification. Templates were stored in a -20°C refrigerator for later use.
蛋白酶K裂解液为自己配制:取5.0ml KCl(1mol/L)、0.25ml MgCl2(1mol/L)、1.5ml Tris-HCl(1mol/L,PH8.0)、Tween-20(20%)混合即为裂解液,裂解液和蛋白酶K(200μg/ml)以50:2的体积混合后,即为DNA模板提取所用的蛋白酶K裂解液。 Prepare proteinase K lysate for yourself: Mix 5.0ml KCl (1mol/L), 0.25ml MgCl2 (1mol/L), 1.5ml Tris-HCl (1mol/L, pH8.0), Tween-20 (20%) It is the lysate. After the lysate and proteinase K (200μg/ml) are mixed at a volume of 50:2, it is the proteinase K lysate used for DNA template extraction.
先参考文献(Teng L J,Zheng X,Glass J I,et al.Ureaplasma urealyticum biovar specificity and diversity are encoded in multiple-banded antigen gene[J].J Clin Microbiol,1994,32(6):1464-1469.)用普通PCR法将临床Uu阳性菌株分为两个生物群,即UPA和UUR,然后再根据上述已建立的荧光定量PCR法把UPA分为4个血清型、UUR分为10个血清型。 First reference (Teng L J, Zheng X, Glass J I, et al. Ureaplasma urealyticum biovar specificity and diversity are encoded in multiple-banded antigen gene[J]. J Clin Microbiol, 1994,32(6):1464-1469.) The clinical Uu-positive strains were divided into two biogroups, namely UPA and UUR, by common PCR method, and then UPA was divided into 4 serotypes and UUR was divided into 10 serotypes according to the above-mentioned established fluorescent quantitative PCR method.
荧光定量PCR反应液:14种血清型均采用20微升反应体系,其中引物和探针的终浓度均为0.2微摩尔每升(uM),镁离子终浓度染料法为2毫摩尔每升(mM),探针法为3mM,染料法加10微升Promega GoTaq qPCR Master Mix,探针法加10微升Invitrogen定量PCR SuperMix-UDG。 Fluorescent quantitative PCR reaction solution: 14 serotypes all use 20 microliters of reaction system, in which the final concentration of primers and probes is 0.2 micromole per liter (uM), and the final concentration of magnesium ion dye method is 2 millimole per liter ( mM), probe method is 3mM, dye method plus 10 microliters Promega GoTaq qPCR Master Mix, probe method plus 10 microliters Invitrogen quantitative PCR SuperMix-UDG.
荧光定量PCR在罗氏Light Cycler480仪器上完成。其中检测血清型1、3、6、14、2、7、8、9、13共9种用的是SYBR染料法,其余5种用Taqman探针法。染料法PCR的条件都包括95℃5分钟的预温,接着40个循环扩增,熔解曲 线的条件为:95℃5秒(速率为4.4℃/s),65℃1分钟(速率为2.2℃/s),97℃(速率为0.11℃/s)连续采集信号模式。最后仪器冷却程序40℃30秒。探针法的条件包括预温50℃和95℃各2分钟,接着扩增程序。最后仪器冷却程序40℃30秒。详细PCR条件见下表。 Fluorescent quantitative PCR was completed on Roche Light Cycler480 instrument. Among them, 9 serotypes 1, 3, 6, 14, 2, 7, 8, 9, and 13 were detected by the SYBR dye method, and the remaining 5 were detected by the Taqman probe method. The conditions of the dye method PCR include a pre-warming at 95°C for 5 minutes, followed by 40 cycles of amplification. The conditions of the melting curve are: 95°C for 5 seconds (the rate is 4.4°C/s), 65°C for 1 minute (the rate is 2.2°C /s), 97°C (0.11°C/s) continuous acquisition signal mode. The final instrument cooling program was 40°C for 30 seconds. Conditions for the probe method included pre-warming at 50°C and 95°C for 2 minutes each, followed by an amplification procedure. The final instrument cooling program was 40°C for 30 seconds. See the table below for detailed PCR conditions.
每次试验都包括阳性对照(相应的标准菌株)和阴性对照(水替代模板)。 Each assay included a positive control (corresponding standard strain) and a negative control (water replacement template).
各血清型特异的引物、探针见下表。 The specific primers and probes for each serotype are shown in the table below.
结果判读,35个循环内有特异性扩增曲线的视为阳性。具体分型结果如图3所示。 Interpretation of the results, if there is a specific amplification curve within 35 cycles, it is considered positive. The specific classification results are shown in Figure 3.
<110> 浙江大学 <110> Zhejiang University
<120> 一种解脲脲原体14种血清型荧光定量PCR检测方法 <120> A fluorescent quantitative PCR detection method for 14 serotypes of Ureaplasma urealyticum
<160> 33 <160> 33
<170> PatentIn version 3.3 <170> PatentIn version 3.3
<210> 1 <210> 1
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 1 <400> 1
aaagcctgtc ttagttctca 20 aaagcctgtc ttagttctca 20
<210> 2 <210> 2
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 2 <400> 2
atactcgtca aggtagtgga 20 atactcgtca aggtagtgga 20
<210> 3 <210> 3
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 3 <400> 3
gctatctcgt tcttgcttca 20 gctatctcgttcttgcttca 20
<210> 4 <210> 4
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 4 <400> 4
tggggatgtt atcattgttc 20 tggggatgtt atcattgttc 20
<210> 5 <210> 5
<211> 19 <211> 19
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 5 <400> 5
gaactttgaa acagctccg 19 gaactttgaa acagctccg 19
<210> 6 <210> 6
<211> 24 <211> 24
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 6 <400> 6
cctggttctt tacctggttc ttta 24 cctggttctt tacctggttc ttta 24
<210> 7 <210> 7
<211> 18 <211> 18
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 7 <400> 7
tgctttactg atccacct 18 tgctttactg atccacct 18
<210> 8 <210> 8
<211> 18 <211> 18
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 8 <400> 8
ttgttccttc aaccctgt 18 ttgttccttc aaccctgt 18
<210> 9 <210> 9
<211> 18 <211> 18
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 9 <400> 9
aggtattcat tgcaccat 18 aggtattcat tgcaccat 18
<210> 10 <210> 10
<211> 18 <211> 18
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 10 <400> 10
gactgatagg cgagtcat 18 gactgatagg cgagtcat 18
<210> 11 <210> 11
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 11 <400> 11
ctaaagcgtg cttaatgtgt 20 ctaaagcgtg cttaatgtgt 20
<210> 12 <210> 12
<211> 19 <211> 19
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 12 <400> 12
gttagtttgg gaaccacct 19 gttagtttgg gaaccacct 19
<210> 13 <210> 13
<211> 35 <211> 35
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 13 <400> 13
tgttattatt atagaaattg ttgtaagaat caaag 35 tgttattatt atagaaattg ttgtaagaat caaag 35
<210> 14 <210> 14
<211> 29 <211> 29
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 14 <400> 14
attatgaaaa attaaactct cattactcg 29 attatgaaaa attaaactct cattactcg 29
<210> 15 <210> 15
<211> 29 <211> 29
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 15 <400> 15
ttctcatatt gaaaagaaaa tgaatgctc 29 ttctcatatt gaaaagaaaa tgaatgctc 29
<210> 16 <210> 16
<211> 35 <211> 35
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 16 <400> 16
aggaagaata aaacatttta atttatatcc acgaa 35 aggaagaata aaacatttta atttatatcc acgaa 35
<210> 17 <210> 17
<211> 18 <211> 18
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 17 <400> 17
gctgttgacc aagctact 18 gctgttgacc aagctact 18
<210> 18 <210> 18
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 18 <400> 18
ttcctttgtt gtaagtgtag 20 ttcctttgtt gtaagtgtag 20
<210> 19 <210> 19
<211> 29 <211> 29
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 19 <400> 19
agttttaatt atttcgttgt ttaagtagc 29 agttttaatt atttcgttgt ttaagtagc 29
<210> 20 <210> 20
<211> 22 <211> 22
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 20 <400> 20
agtttttacg tggtaagtgg tt 22 agtttttacg tggtaagtgg tt 22
<210> 21 <210> 21
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 21 <400> 21
tagatgagcg acttcatacc 20 tagatgagcg acttcatacc 20
<210> 22 <210> 22
<211> 20 <211> 20
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 22 <400> 22
taactcgtga gcctgttgtg 20 taactcgtga gcctgttgtg 20
<210> 23 <210> 23
<211> 22 <211> 22
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 23 <400> 23
tgcatcaaca tcgctaaatt ca 22 tgcatcaaca tcgctaaatt ca 22
<210> 24 <210> 24
<211> 17 <211> 17
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 24 <400> 24
atacgcctac tccgact 17 atacgcctac tccgact 17
<210> 25 <210> 25
<211> 22 <211> 22
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 25 <400> 25
ttggtgtagg tgttggttgt gg 22 ttggtgtagg tgttggttgt gg 22
<210> 26 <210> 26
<211> 30 <211> 30
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 26 <400> 26
aaccttatca attctattaa tcatagttca 30 aaccttatca attctattaa tcatagttca 30
<210> 27 <210> 27
<211> 21 <211> 21
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 27 <400> 27
tgaaaacaaa aaacacgctc c 21 tgaaaacaaaaaacacgctc c 21
<210> 28 <210> 28
<211> 26 <211> 26
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 28 <400> 28
aaaccaaact aacacattaa gcacgc 26 aaaccaaact aacacattaa gcacgc 26
<210> 29 <210> 29
<211> 23 <211> 23
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 29 <400> 29
aattggtcaa acaacatatc gtg 23 aattggtcaa acaacatatc gtg 23
<210> 30 <210> 30
<211> 29 <211> 29
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 30 <400> 30
atttaacacg attaacatct tcacgttta 29 atttaacacg attaacatct tcacgttta 29
<210> 31 <210> 31
<211> 25 <211> 25
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 31 <400> 31
tttgcgaagc attaccgcca aatac 25 tttgcgaagc attaccgcca aatac 25
<210> 32 <210> 32
<211> 18 <211> 18
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 32 <400> 32
agaacacttc acgcctcg 18 agaacacttc acgcctcg 18
<210> 33 <210> 33
<211> 21 <211> 21
<212> DNA <212>DNA
<213> 人工序列 <213> Artificial sequence
<400> 33 <400> 33
ttcccatacc aagagtacca c 21 ttcccatacc aagagtacca c 21
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410113941.6A CN103966315A (en) | 2014-03-25 | 2014-03-25 | Fluorescence quantitative PCR (polymerase chain reaction) detection method for 14 serotypes of Uu (ureaplasma urealyticum) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410113941.6A CN103966315A (en) | 2014-03-25 | 2014-03-25 | Fluorescence quantitative PCR (polymerase chain reaction) detection method for 14 serotypes of Uu (ureaplasma urealyticum) |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103966315A true CN103966315A (en) | 2014-08-06 |
Family
ID=51236317
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410113941.6A Pending CN103966315A (en) | 2014-03-25 | 2014-03-25 | Fluorescence quantitative PCR (polymerase chain reaction) detection method for 14 serotypes of Uu (ureaplasma urealyticum) |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103966315A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999039007A1 (en) * | 1998-01-30 | 1999-08-05 | The Uab Research Foundation | NUCLEIC ACID PROBES AND METHOD FOR DETECTING $i(UREAPLASMA UREALYTICUM) |
CN1873024A (en) * | 2006-04-14 | 2006-12-06 | 武汉大学 | Fluorescence quantitative kit PCR for quick testing fine |
CN102952888A (en) * | 2011-12-20 | 2013-03-06 | 天津医科大学 | Method for detecting ureaplasma urealyticum and tiny urealyticum |
-
2014
- 2014-03-25 CN CN201410113941.6A patent/CN103966315A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999039007A1 (en) * | 1998-01-30 | 1999-08-05 | The Uab Research Foundation | NUCLEIC ACID PROBES AND METHOD FOR DETECTING $i(UREAPLASMA UREALYTICUM) |
CN1873024A (en) * | 2006-04-14 | 2006-12-06 | 武汉大学 | Fluorescence quantitative kit PCR for quick testing fine |
CN102952888A (en) * | 2011-12-20 | 2013-03-06 | 天津医科大学 | Method for detecting ureaplasma urealyticum and tiny urealyticum |
Non-Patent Citations (1)
Title |
---|
刘志伟: "52例输卵管性不孕女性生殖道中Uu血清型分布状况研究", 《中国优秀硕士学位论文全文数据库》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Park et al. | Comparison of phenotypic and genotypic methods for the species identification of coagulase-negative staphylococcal isolates from bovine intramammary infections | |
CN109593868B (en) | Characteristic nucleotide sequence for detecting pseudomonas bacteria, and specific primer, kit and detection method thereof | |
CN107513584A (en) | A five-fold fluorescence quantitative kit for detecting enteroviruses | |
CN110578017A (en) | Kit for synchronously detecting twenty-three respiratory pathogens and detection method thereof | |
CN114085917B (en) | Method and kit for rapid and visual detection of Shigella flexneri based on CRISPR/Cas12a-LAMP | |
CN102382879B (en) | Pseudomonas fluorescens LAMP (loop-mediated isothermal amplification) detection agent and kit | |
CN105734164A (en) | Multiplex PCR kit for detecting bacterial meningitis pathogens | |
CN107686863A (en) | The method that loop-mediated isothermal amplification technique detects three kinds of Urogenital Mycoplasmas | |
CN112280878B (en) | Specific target spot, primer, detection method and application for detecting vibrio parahaemolyticus | |
CN102618625A (en) | Method and kit for detecting drug resistance of mycobacterium tuberculosis | |
EP4240877A1 (en) | Multiplex detection of bacterial respiratory pathogens | |
CN104946769B (en) | The kit of mycoplasma pneumoniae quick detection and Genotyping | |
CN103667439B (en) | Real-time quantitative polymerase chain reaction (PCR) method using double probe and capable of distinguishing B-type and non-B-type hepatitis B virus (HBV) | |
CN102605048B (en) | Specific primer sequence, probe sequence and method for simultaneous detection of oat cyst nematode and philip cyst nematode | |
CN101875974A (en) | Primer set, detection kit and detection method for detecting B. pertussis | |
CN102168131B (en) | Primers for Amplifying Specific Regions of Common Pathogenic Legionella gyrB Genes and Their Applications | |
CN105154538B (en) | The primer and method of a kind of Legionella quick detection and parting | |
CN105219847B (en) | A kind of Legionella quick detection and parting kit and its detection method | |
CN111876506A (en) | Multiple fluorescent quantitative PCR primer, probe and kit for detecting toxigenic clostridium difficile | |
CN103205485A (en) | Method of detecting nucleotides of Bacillus cereus, primers for detecting and probes | |
CN106868218A (en) | For the multiple PCR reagent kit of viral encephalitis quick diagnosis | |
CN110846428A (en) | Specific LAMP primers, kits and methods for the detection of Streptococcus agalactiae | |
CN110079620A (en) | Identify three kinds of nocardial methods simultaneously using high-resolution melting curve method | |
CN103966315A (en) | Fluorescence quantitative PCR (polymerase chain reaction) detection method for 14 serotypes of Uu (ureaplasma urealyticum) | |
CN116516036A (en) | Primer and probe combination and application of a LAMP method for detecting Pantoea pineapple |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140806 |